End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.91 CNY | -0.73% |
|
-0.33% | +3.28% |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.48 for the current year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.28% | 967M | - | ||
+62.66% | 854B | C+ | ||
+40.42% | 636B | B | ||
-4.37% | 361B | C+ | ||
+17.16% | 324B | B- | ||
+9.87% | 301B | C+ | ||
+15.66% | 247B | B+ | ||
+4.21% | 230B | A+ | ||
+17.90% | 228B | B- | ||
+14.86% | 177B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 000915 Stock
- Ratings Shandong Wit Dyne Health Co.,Ltd.